Medidata Solutions Inc (MDSO)

52.43
0.16 0.30
NASDAQ : Technology
Prev Close 52.59
Open 52.94
Day Low/High 52.24 / 53.39
52 Wk Low/High 30.22 / 54.99
Volume 379.21K
Avg Volume 515.80K
Exchange NASDAQ
Shares Outstanding 57.63M
Market Cap 3.06B
EPS 0.20
P/E Ratio 120.54
Div & Yield N.A. (N.A)

Latest News

Medidata Introduces EConnect Partner Program

Medidata Introduces EConnect Partner Program

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced the launch of the Medidata eConnect Partner Program.

Medidata Honors Chiltern With Inaugural Architect Of Hope Award, Celebrating Innovation In Life Sciences

Medidata Honors Chiltern With Inaugural Architect Of Hope Award, Celebrating Innovation In Life Sciences

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that Chiltern, a leading global contract research organization (CRO), is one of...

French Biopharma Invests In Medidata Technology To Drive Cutting-Edge Cancer And Rare Disease Research

French Biopharma Invests In Medidata Technology To Drive Cutting-Edge Cancer And Rare Disease Research

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Erytech Pharma ("Erytech"), a French biopharmaceutical company developing...

Medidata To Host Financial Analyst Day In New York City On November 18

Medidata To Host Financial Analyst Day In New York City On November 18

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will host a financial analyst day on Friday, November 18, 2016 in New York City.

Japan's Nobelpharma Selects Medidata As Technology Partner For New Clinical Study On Sleep Disorders

Japan's Nobelpharma Selects Medidata As Technology Partner For New Clinical Study On Sleep Disorders

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that the Medidata Clinical Cloud ® has been adopted by Nobelpharma to...

Medidata Reports Record Third Quarter 2016 Results

Medidata Reports Record Third Quarter 2016 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the third quarter of 2016.

LifeMap Solutions Joins Medidata AppConnect Partner Program To Drive MHealth Innovation

LifeMap Solutions Joins Medidata AppConnect Partner Program To Drive MHealth Innovation

LifeMap Solutions, the digital health subsidiary of BioTime, Inc. (NYSE MKT: BTX), today announced a partnership with Medidata (NASDAQ: MDSO), the leading provider of cloud-based solutions for clinical research.

Medidata Unveils AppConnect Partner Program

Medidata Unveils AppConnect Partner Program

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the launch of its AppConnect Partner Program in support of mobile health (mHealth)...

Medidata Schedules Third Quarter Earnings Conference Call For October 25, 2016

Medidata Schedules Third Quarter Earnings Conference Call For October 25, 2016

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its third quarter 2016 financial results before the open of the...

Society For Clinical Research Sites And Medidata Launch Advisory Group In Support Of Clinical Trial Investigators And Research Sites

Society For Clinical Research Sites And Medidata Launch Advisory Group In Support Of Clinical Trial Investigators And Research Sites

The Society for Clinical Research Sites (SCRS) and global clinical trial technology and data analytics leader Medidata (NASDAQ:MDSO) today announced the launch of a clinical trial Site Advisory Group (SAG).

Polaris Pharmaceuticals Adopts Medidata Payments

Polaris Pharmaceuticals Adopts Medidata Payments

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that multinational pharmaceutical company Polaris Pharmaceuticals, Inc.

University Of North Carolina Wilmington Partners With Medidata To Bring Clinical Cloud Technology To The Classroom

University Of North Carolina Wilmington Partners With Medidata To Bring Clinical Cloud Technology To The Classroom

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and the University of North Carolina Wilmington (UNCW) have announced a new partnership to educate...

Medidata To Present At Deutsche Bank 2016 Technology Conference

Medidata To Present At Deutsche Bank 2016 Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer,...

Medidata And Techfields Launch MHealth Stroke Study

Medidata And Techfields Launch MHealth Stroke Study

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, announced today that Techfields Pharma ("Techfields") has selected the Medidata Clinical...

Medidata And SHYFT Analytics Form Commercial Partnership

Medidata And SHYFT Analytics Form Commercial Partnership

Medidata (NASDAQ:MDSO) and SHYFT Analytics (SHYFT) today announced a strategic commercial partnership to increase access to healthcare data analytics in clinical trials.

Medidata To Present At Citi 2016 Global Technology Conference

Medidata To Present At Citi 2016 Global Technology Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Mike Capone, chief operating officer, and Rouven Bergmann, chief financial officer,...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ASFI, BCOM, CDOR, CYBE, MDSO, RELL, SQM, TRNC Downgrades: LPNT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Pluristem Therapeutics Deploys Medidata's Cloud Technology

Pluristem Therapeutics Deploys Medidata's Cloud Technology

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, announced today that its cloud technology platform has been adopted by Pluristem Therapeutics Inc.

Medidata To Present At Pacific Crest Global Technology Leadership Conference

Medidata To Present At Pacific Crest Global Technology Leadership Conference

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the 18th Annual...

Medidata's April Mulroney Honored Among PharmaVOICE 100's Most Inspiring People

Medidata's April Mulroney Honored Among PharmaVOICE 100's Most Inspiring People

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that its own April Mulroney has been recognized by PharmaVOICE magazine as...

New Cancer-Focused Biotech Forty Seven Inc. Selects Medidata To Accelerate Novel Immuno-Oncology R&D

New Cancer-Focused Biotech Forty Seven Inc. Selects Medidata To Accelerate Novel Immuno-Oncology R&D

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Forty Seven Inc.

Insider Trading Alert - MDSO, BDN And COBZ Traded By Insiders

Insider Trading Alert - MDSO, BDN And COBZ Traded By Insiders

Stocks with insider trader activity include MDSO, BDN and COBZ

Medidata Cloud Technology Selected To Support Biogen Clinical Trials

Medidata Cloud Technology Selected To Support Biogen Clinical Trials

Medidata (NASDAQ: MDSO) today announced that its cloud technology has been selected by Biogen to support future clinical trials.

Stock To Watch: Medidata Solutions (MDSO) In Perilous Reversal

Stock To Watch: Medidata Solutions (MDSO) In Perilous Reversal

Trade-Ideas LLC identified Medidata Solutions (MDSO) as a "perilous reversal" (up big yesterday but down big today) candidate

Medidata Solutions Reaches Analyst Target Price

Medidata Solutions Reaches Analyst Target Price

In recent trading, shares of Medidata Solutions, Inc. have crossed above the average analyst 12-month target price of $48.57, changing hands for $53.58/share.

Medidata Solutions (MDSO) Is Strong On High Volume Today

Medidata Solutions (MDSO) Is Strong On High Volume Today

Trade-Ideas LLC identified Medidata Solutions (MDSO) as a strong on high relative volume candidate

Medidata Reports Record Second Quarter 2016 Results

Medidata Reports Record Second Quarter 2016 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the second quarter of 2016.

Medidata Collaborates With Leading New York Cancer Center To Expand The Use Of MHealth Technology In Oncology Care

Medidata Collaborates With Leading New York Cancer Center To Expand The Use Of MHealth Technology In Oncology Care

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced it is collaborating with Memorial Sloan Kettering Cancer Center (MSK) to expand the...